Leaderboards/atrial fibrillation management and outcomes

atrial fibrillation management and outcomes

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
M. C. Chu
Jiangsu Province Hospital
99
2
Shanshan Lu
Jiangsu Province Hospital
90
3
Emma Svennberg
Karolinska University Hospital
60
4
José Luís Merino
Hospital Universitario La Paz
50
5
Sandra Ortega‐Martorell
University of Liverpool
40
6
Rungroj Krittayaphong
Siriraj Hospital
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Dominik Linz
University of Copenhagen
99
2
Louise Segan
Baker Heart and Diabetes Institute
80
3
Ibrahim Antoun
University of Aleppo
80
4
Giulio Francesco Romiti
University of Liverpool
70
5
Marco Bergonti
Ente Ospedaliero Cantonale
60
6
Salim S. Hayek
American Heart Association
50
7
Alvi Rahman
Jewish General Hospital
30
8
Josefin Särnholm
Karolinska Institutet
20
9
Mahesh Pakhare
Jawaharlal Nehru Medical College
10

Emerging Leaders Papers

1
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry
BMC Medicine|2024
50 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Daniel E. Singer
Kaiser Permanente
99
2
Prashanthan Sanders
Royal Adelaide Hospital
90
3
Tze‐Fan Chao
National Yang Ming Chiao Tung University
90
4
Günter Breithardt
Universität Hamburg
80
5
Mustafa Zakkar
University of Leicester
70
6
Gregory Y.H. Lip
University of Birmingham
70
7
Bertram Pitt
National Heart Lung and Blood Institute
60
8
A. Jamil Tajik
Mayo Clinic
50
9
Tommaso Bucci
University of Liverpool
40
10
Regina Kunz
Swiss Academy of Medical Sciences
40

All-Time Leaders Papers

1
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
BMJ|2016
442 cit.
2
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
Health Technology Assessment|2005
432 cit.
3
Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation
Circulation|2016
122 cit.
4
Microparticles and cardiovascular diseases
Annals of Medicine|2019
54 cit.
5
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
Heart|2016
44 cit.
6
Prevalence of Heart Failure and Atrial Fibrillation in Minority Ethnic Subjects: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
PLoS ONE|2011
43 cit.
7
Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis
Journal of Clinical Medicine|2020
35 cit.
8
Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in patients with atrial fibrillation: a prospective study from UK Biobank
British Journal of Sports Medicine|2024
18 cit.
9
Dexamethasone modulate TWIST mediated EndMT changes in venous EC under acute shear stress. Implications for vein grafts disease
medRxiv|2023
1 cit.

Reagents for atrial fibrillation management and outcomes

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Tec (F2K5K) Rabbit Monoclonal Antibody

#99987$161
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

ADAR1 (E6X9R) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

#99623$465
View Evidence →Cell Signaling Technology

PA28 gamma Antibody

#2412$317
View Evidence →Cell Signaling Technology

GPNMB (E4D7P) Rabbit Monoclonal Antibody (BSA and Azide Free)

#79846$865
View Evidence →

🌟 All-Time

Most validated

InnoCyto

Anti-c-Myc Antibody

Cited in 15 papers
#300901
View Evidence →Cell Signaling Technology

SHIP2 Antibody

Cited in 6 papers
#2730$317
View Evidence →Cell Signaling Technology

Vimentin (D21H3) Rabbit Monoclonal Antibody (APC Conjugate)

Cited in 5 papers
#95159$465
View Evidence →